Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,013 public trials 2,032 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

EXHIT ENTRE Comparative Effectiveness Trial

NCT04345718

Conditions
Chemically-Induced Disorders, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations
  • Yale New Haven Hospital New Haven, Connecticut, United States
  • Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Boston University Boston, Massachusetts, United States
View Trial Details
Completed

Rituximab, Bendamustine and Cytarabine Followed by Venetoclax in High Risk Elderly Patients With MCL

NCT03567876

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • A.O. SS. Antonio e Biagio e Cesare Arrigo, SC Ematologia Alessandria, Italy
  • Università Politecnica delle Marche, Clinica di Ematologia Ancona, Italy
  • Centro Riferimento Oncologico, S.O.C. Oncologia Medica A Aviano, Italy
  • IRCCS Istituto Tumori Giovanni Paolo II, UOC Ematologia Bari, Italy
View all 35 locations
View Trial Details
Completed

A Study of the Safety and Efficacy of Venetoclax for Participants With Chronic Lymphocytic Leukemia (CLL) Used in Routine Clinical Practice

NCT04178317

Conditions
Cancer, Chronic Lymphocytic Leukemia (CLL), Chronic Disease, Disease Attributes, +14 more
Locations
  • Inje University - Busan Paik Hospital /ID# 233882 Busan, Busan Gwang Yeogsi, South Korea
  • Pusan National University Hospital /ID# 216850 Busan, Busan Gwang Yeogsi, South Korea
  • Kyungpook National University Hospital /ID# 233884 Daegu, Daegu Gwang Yeogsi, South Korea
  • The catholic university of korea st. Paul's hospital /ID# 238907 Seoul, Gyeonggido, South Korea
View all 13 locations
View Trial Details
Completed

ItaliaN Observational Study of Patients With Acute Lymphoblastic Leukemia Treated With Anti-CD22 Immunoconjugate

NCT03898128

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Irst Irccs Meldola (FC), FC, Italy
  • AUSL Romagna Ravenna, RA, Italy
  • Azienda ULSS2 Marca Trevigiana Treviso, TV, Italy
  • ULSS 3 Serenissima Mestre, Venezia, Italy
View Trial Details

Related conditions